Skip to main content
Premium Trial:

Request an Annual Quote

LabCorp to Sell Roche's AmpliPrep/COBAS TaqMan HIV-1 Dx

NEW YORK (GenomeWeb News) — Laboratory Corporation of America will be the first commercial laboratory in the US to sell Roche Diagnostics' AmpliPrep/COBAS TaqMan HIV-1 test, the company said today.
 
The US Food & Drug Administration approved the real-time PCR test May 11.
 
The product quantifies the amount of HIV virus in the blood to enable doctors to establish a baseline HIV infection level before starting treatment. They could also use the test to monitor patients' responses during treatment.
 
In a statement, LabCorp said the test’s ability to fully automate sample preparation, amplification, and detection in a standardized process “will eliminate a number of manual steps and enhance the total quality process.”
 
Financial terms of the agreement were not disclosed.